Who is hitting up Avengers: Endgame Encore?!? I’m heading there soon

Who is hitting up Avengers: Endgame Encore?!? I’m heading there soon
📈 The primary end point of CELESTIMO was met with mosunetuzumab plus lenalidomide showing a statistically significant PFS improvement vs rituximab plus lenalidomide in R/R follicular lymphoma.
Read more here 📰: onclive.com/view/mosunet...
#Drug doubles life expectancy of pancreatic cancer patients 💊
The #FDA approved #daraxonrasib, from Revolution Medicines, after patients in a #Phase3 clinical trial lived twice as long as those on #chemotherapy. The drug was studied in #mice and #monkeys before #HumanTrials.
🔗 shorturl.at/BHYZd